When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

RSV leads to over 100,000 infant deaths annually, but WHO’s latest guidance recommends maternal vaccines and monoclonal ...

Respiratory syncytial virus (RSV) causes millions of childhood illnesses yearly, particularly in poorer countries. On 30 May ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...

Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

“I had actually only heard of RSV in passing conversation. I hadn't actually looked after anyone with RSV,” she explained.

New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.

Experts say new immunisation program working, but some babies missing outThe number of Australian babies admitted to hospital ...